 |
Rilonacept |
|---|---|
| Trade Name | |
| Orphan Indication | Deficiency of interleukin-1 receptor antagonist (DIRA) |
| USA Market Approval | USA |
| USA Designation Date | 2017-05-09 00:00:00 |
| Sponsor | Regeneron Pharmaceuticals, Inc.;777 Old Saw Mill River Road;Tarrytown, New York, 10591 |
